Entropy Neurodynamics Limited (ASX:ENP)
Australia · Delayed Price · Currency is AUD 0.0380
-0.0015 (-3.80%)
Oct 1, 2026, 1:48 PM AEST
Entropy Neurodynamics Market Cap
Entropy Neurodynamics has a market cap or net worth of 62.89 million as of October 1, 2026. Its market cap has increased by 6.53% in one year.
Market Cap
62.89M
Enterprise Value
57.32M
Revenue
1.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.04
ChartMarket Cap Chart
Since May 29, 2024, Entropy Neurodynamics's market cap has increased from 38.06M to 62.89M, an increase of 65.24%. That is a compound annual growth rate of 23.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 1, 2026 | 62.89M | 22.20% |
| Dec 31, 2025 | 51.47M | 6.11% |
| Dec 31, 2024 | 48.50M | 27.43% |
| May 29, 2024 | 38.06M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Island Pharmaceuticals | 115.41M |
| Recce Pharmaceuticals | 100.90M |
| Alterity Therapeutics | 88.28M |
| LTR Pharma | 84.53M |
| Prescient Therapeutics | 73.61M |
| Avecho Biotechnology | 73.41M |
| Amplia Therapeutics | 61.60M |
| Arovella Therapeutics | 59.23M |